| Company Name: |
BOC Sciences |
| Tel: |
+1-631-485-4226 |
| Email: |
inquiry@bocsci.com |
Atovaquone D4 manufacturers
- Atovaquone-D4
-
- $568.00
-
2026-05-11
- CAS:2070015-14-2
- Purity:
- Supply Ability: 10g
|
| | Atovaquone D4 Basic information |
| Product Name: | Atovaquone D4 | | Synonyms: | 2-[trans-4-(4-chlorophenyl)cyclohexyl]-3-hydroxy-1,4-naphthalenedione-5,6,7,8-d4;Atovaquone D4 (naphthalene-D4);2-hydroxy-3-[(1r,4r)-4-(4-chlorophenyl)cyclohexyl]-1,4-dihydro(2H?)naphthalene-1,4-dione;Atovaquone-D4;Atavaquone-d4;Atovaquone D4Q: What is
Atovaquone D4 Q: What is the CAS Number of
Atovaquone D4 Q: What is the storage condition of
Atovaquone D4 Q: What are the applications of
Atovaquone D4 | | CAS: | 2070015-14-2 | | MF: | C22H19ClO3 | | MW: | 366.84 | | EINECS: | | | Product Categories: | | | Mol File: | 2070015-14-2.mol |  |
| | Atovaquone D4 Chemical Properties |
| storage temp. | Store at -20°C | | solubility | Chloroform: soluble | | form | A solid | | color | Light yellow to yellow |
| | Atovaquone D4 Usage And Synthesis |
| Uses | Atovaquone-d4is the deuterium labeled Atovaquone. Atovaquone is a medication used to treat or prevent for pneumocystis pneumonia, toxoplasmosis, malaria, and babesia[1]. | | IC 50 | Plasmodium | | References | [1] Looareesuwan, S., et al., Clinical studies of atovaquone, alone or in combination with other antimalarial drugs, for treatment of acute uncomplicated malaria in Thailand. Am J Trop Med Hyg, 1996. 54(1): p. 62-6. DOI:10.4269/ajtmh.1996.54.62 |
| | Atovaquone D4 Preparation Products And Raw materials |
|